75 /100
HIGH RISK
Score updated May 16, 2026

DUOT — Duos Technologies Group, Inc. Dilution Risk Tracker

Track DUOT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DUOT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
85
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
47%
🔁 Convertible Conversion 60%
• Major convertible overhang: 221% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 53%
• Under 12 months cash (6mo)
• Active shelf registration ($250M, 95% of market cap)
📉 Score Deterioration 10%
• Score in HIGH risk zone (75/100)
🔔 Track DUOT — Get forecast alerts →

💹 Market Data

Market Cap$262.78M
Shares Outstanding29.30M
Float26.22M
Cash$15.47M
Debt$4.64M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 5.4% shares (2025Q4 vs prior)
56 institutional holders · 7.83M shares
#1 Bleichroeder LP 1.63M shares
#2 ROYAL BANK OF CANADA 965.4K shares
#3 MORGAN STANLEY 807.6K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.70M
Days to Cover4.1
% of Float6.5%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
xbrl XBRL WARRANT Dec 31, 2024
8-K 8K EVENT Mar 02, 2026
424B5 ATM Mar 02, 2026
424B5 ATM Feb 26, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track DUOT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DUOT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for DUOT
📊 DUOT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DUOT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.